Verdence Capital Advisors LLC Adaptive Biotechnologies Corp Transaction History
Verdence Capital Advisors LLC
- $1.28 Billion
- Q1 2025
A detailed history of Verdence Capital Advisors LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 20,889 shares of ADPT stock, worth $186,120. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,889Holding current value
$186,120% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$267 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$117 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$99.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$68.9 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.27B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...